October 2005
Publications reviewed for Global Strategy for the Asthma Management and
Prevention (GINA Workshop Report) - Updated 2005
The manuscripts listed below were chosen according to the methodology described by the
GINA Science Committee. Details are provided in the section “Methodology and
Summary of Recommendations (2005 update)” on page iii in the Report.
Manuscripts published January 1 to December 31, 2004 selected from Pub Med search using fields:

Asthma, All Fields, All ages, only items with abstracts, Clinical Trial, Human, sorted by Authors; and

Asthma systematic, All fields, All ages, only items with abstracts, Human, sorted by Author. (This selects the review articles).
1. Quick reference guide for clinicians: systematic review of the evidence regarding potential complications of inhaled steroid use in asthma. Ann Allergy Asthma Immunol
2004;92(3):291-293.
2. Aalbers R, Backer V, Kava TT, Omenaas ER, Sandstrom T, Jorup C, Welte T.
Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma. Curr Med Res Opin 2004;20(2):225-
240.
3. Abadoglu O, Mungan D, Pasaoglu G, Celik G, Misirligil Z. Influenza vaccination in patients with asthma: effect on the frequency of upper respiratory tract infections and exacerbations. J Asthma 2004;41(3):279-283.
4. Adoun M, Frat JP, Dore P, Rouffineau J, Godet C, Robert R. Comparison of nebulized epinephrine and terbutaline in patients with acute severe asthma: a controlled trial. J Crit
Care 2004;19(2):99-102.
5. Ahlstrom-Emanuelsson C, Andersson M, Persson C, Schrewelius C, Greiff L. Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollenseason model of allergic rhinitis. Clin Exp Allergy 2004;34(5):731-735.
6. Akil I, Yuksel H, Urk V, Var A, Onur E. Biochemical markers of bone metabolism and calciuria with inhaled budesonide therapy. Pediatr Nephrol 2004;19(5):511-515.
7. Amirav I, Mansour Y, Mandelberg A, Bar-Ilan I, Newhouse MT. Redesigned face mask improves "real life" aerosol delivery for Nebuchamber. Pediatr Pulmonol
2004;37(2):172-177.
8. Amirav I, Tiosano T, Chamny S, Chirurg S, Oren S, Grossman Z, Kahan E, Newhouse
MT, Mansour Y. Comparison of efficiency and preference of metal and plastic spacers in preschool children. Ann Allergy Asthma Immunol 2004;93(3):249-252.
9. Arikan C, Bahceciler NN, Deniz G, Akdis M, Akkoc T, Akdis CA, Barlan IB. Bacillus
Calmette-Guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy.
Clin Exp Allergy 2004;34(3):398-405.

10. Arvidsson MB, Lowhagen O, Rak S. Allergen specific immunotherapy attenuates early and late phase reactions in lower airways of birch pollen asthmatic patients: a double blind placebo-controlled study. Allergy 2004;59(1):74-80.
11. Athavale A, Souza GA, Avasthi R, Singh NP, Kale M, Taneja A, Sireesha K. A clinical trial of the efficacy and safety of montelukast as monotherapy in patients with chronic stable bronchial asthma. J Indian Med Assoc 2004;102(2):109-111.
12. Avila PC, Boushey HA, Wong H, Grundland H, Liu J, Fahy JV. Effect of a single dose of the selectin inhibitor TBC1269 on early and late asthmatic responses. Clin Exp
Allergy 2004;34(1):77-84.
13. Avila-Castanon L, Casas-Becerra B, Del Rio-Navarro BE, Velazquez-Armenta Y,
Sienra-Monge JJ. Formoterol vs. albuterol administered via Turbuhaler system in the emergency treatment of acute asthma in children. Allergol Immunopathol (Madr)
2004;32(1):18-20.
14. Bacharier LB, Raissy HH, Wilson L, McWilliams B, Strunk RC, Kelly HW. Longterm effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma. Pediatrics 2004;113(6):1693-1699.
15. Bacharier LB, Strunk RC, Mauger D, White D, Lemanske RF, Jr., Sorkness CA.
Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med 2004;170(4):426-432.
16. Bachert C, Bousquet J, Canonica GW, Durham SR, Klimek L, Mullol J, Van
Cauwenberge PB, Van Hammee G. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol
2004;114(4):838-844.
17. Balon JW, Mior SA. Chiropractic care in asthma and allergy. Ann Allergy Asthma
Immunol 2004;93(2 Suppl 1):S55-60.
18. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen
SE. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma
ControL study. Am J Respir Crit Care Med 2004;170(8):836-844.
19. Becker A, Swern A, Tozzi CA, Yu Q, Reiss T, Knorr B. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%. Curr Med Res Opin
2004;20(10):1651-1659.
20. Beden C, Helleboid L, Marmouz F, Liard F. [A comparative study of the ocular tolerance after administration of anti-allergic eye drops with or without a preservative].
Therapie 2004;59(2):259-264.
21. Bergen R, Black S, Shinefield H, Lewis E, Ray P, Hansen J, Walker R, Hessel C,
Cordova J, Mendelman PM. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr Infect Dis J 2004;23(2):138-144.
22. Bergmann KC, Lindemann L, Braun R, Steinkamp G. Salmeterol/fluticasone propionate (50/250 microg) combination is superior to double dose fluticasone (500 microg) for the treatment of symptomatic moderate asthma. Swiss Med Wkly
2004;134(3-4):50-58.
23. Bisgaard H, Allen D, Milanowski J, Kalev I, Willits L, Davies P. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics 2004;113(2):e87-94.

24. Black J, Baxter-Jones AD, Gordon J, Findlay AL, Helms PJ. Assessment of airway function in young children with asthma: comparison of spirometry, interrupter technique, and tidal flow by inductance plethsmography. Pediatr Pulmonol 2004;37(6):548-553.
25. Boulet LP, Cartier A, Ernst P, Larivee P, Laviolette M. Safety and efficacy of HFA-
134a beclomethasone dipropionate extra-fine aerosol over six months. Can Respir J
2004;11(2):123-130.
26. Bourdin A, Serre I, Flamme H, Vic P, Neveu D, Aubas P, Godard P, Chanez P. Can endobronchial biopsy analysis be recommended to discriminate between asthma and
COPD in routine practice? Thorax 2004;59(6):488-493.
27. Bousquet J, Wenzel S, Holgate S, Lumry W, Freeman P, Fox H. Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma. Chest
2004;125(4):1378-1386.
28. Brown ES, D JW, Frol A, Bobadilla L, Khan DA, Hanczyc M, Rush AJ, Fleckenstein
J, Babcock E, Cullum CM. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry 2004;55(5):538-545.
29. Brown R, Bratton SL, Cabana MD, Kaciroti N, Clark NM. Physician asthma education program improves outcomes for children of low-income families. Chest
2004;126(2):369-374.
30. Brown NJ, Thorpe CW, Thompson B, Berend N, Downie S, Verbanck S, Salome
CM, King GG. A comparison of two methods for measuring airway distensibility: nitrogen washout and the forced oscillation technique. Physiol Meas 2004;25(4):1067-
1075.
31. Bueving HJ, Bernsen RM, de Jongste JC, van Suijlekom-Smit LW, Rimmelzwaan
GF, Osterhaus AD, Rutten-van Molken MP, Thomas S, van der Wouden JC. Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial.
Am J Respir Crit Care Med 2004;169(4):488-493.
32. Bueving HJ, Bernsen RM, de Jongste JC, van Suijlekom-Smit LW, Rimmelzwaan
GF, Osterhaus AD, Rutten-van Molken MP, Thomas S, van der Wouden JC. Does influenza vaccination exacerbate asthma in children? Vaccine 2004;23(1):91-96.
33. Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz
T, Braun W. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy
2004;59(5):498-504.
34. Buhl R, Kardos P, Richter K, Meyer-Sabellek W, Bruggenjurgen B, Willich SN,
Vogelmeier C. The effect of adjustable dosing with budesonide/formoterol on healthrelated quality of life and asthma control compared with fixed dosing. Curr Med Res
Opin 2004;20(8):1209-1220.
35. Bumbacea D, Scheerens J, Mann BS, Stirling RG, Chung KF. Failure of sputum eosinophilia after eotaxin inhalation in asthma. Thorax 2004;59(5):372-375.
36. Cabana MD, Slish KK, Lewis TC, Brown RW, Nan B, Lin X, Clark NM. Parental management of asthma triggers within a child's environment. J Allergy Clin Immunol
2004;114(2):352-357.
37. Camargos PA, Rodrigues ME, Lasmar LM. Simultaneous treatment of asthma and allergic rhinitis. Pediatr Pulmonol 2004;38(3):186-192.

38. Camp PG, Dimich-Ward H, Kennedy SM. Women and occupational lung disease: sex differences and gender influences on research and disease outcomes. Clin Chest Med
2004;25(2):269-279.
39. Campbell IA, Douglas JG, Francis RM, Prescott RJ, Reid DM. Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids. Thorax
2004;59(9):761-768.
40. Campos FL, da Silva-Junior FP, de Bruin VM, de Bruin PF. Melatonin improves sleep in asthma: a randomized, double-blind, placebo-controlled study. Am J Respir Crit
Care Med 2004;170(9):947-951.
41. Canonica GW, Castellani P, Cazzola M, Fabbri LM, Fogliani V, Mangrella M,
Moretti A, Paggiaro P, Sanguinetti CM, Vignola AM. Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing. Pulm Pharmacol Ther
2004;17(4):239-247.
42. Castro-Rodriguez JA, Rodrigo GJ. beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. J Pediatr
2004;145(2):172-177.
43. Cates CJ, Jefferson TO, Bara AI, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev 2004(2):CD000364.
44. Cegla UH. Pressure and inspiratory flow characteristics of dry powder inhalers.
Respir Med 2004;98 Suppl A:S22-28.
45. Chang AB, Wilson S, Masters IB, Harrhy VA, Hubbard M. Effect of inspiratory flow on methacholine challenge in children. J Asthma 2004;41(3):349-354.
46. Chen LL, Tager IB, Peden DB, Christian DL, Ferrando RE, Welch BS, Balmes JR.
Effect of ozone exposure on airway responses to inhaled allergen in asthmatic subjects.
Chest 2004;125(6):2328-2335.
47. Chiang LC, Huang JL, Yeh KW, Lu CM. Effects of a self-management asthma educational program in Taiwan based on PRECEDE-PROCEED model for parents with asthmatic children. J Asthma 2004;41(2):205-215.
48. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M,
Muller B. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
Lancet 2004;363(9409):600-607.
49. Ciprandi G, Tosca MA, Milanese M, Schenone G, Ricca V. Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism. Allerg Immunol (Paris) 2004;36(2):67-70, 72.
50. Clark NM, Brown R, Joseph CL, Anderson EW, Liu M, Valerio MA. Effects of a comprehensive school-based asthma program on symptoms, parent management, grades, and absenteeism. Chest 2004;125(5):1674-1679.
51. Cosio BG, Mann B, Ito K, Jazrawi E, Barnes PJ, Chung KF, Adcock IM. Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. Am J Respir Crit Care Med 2004;170(2):141-147.

52. Covar RA, Spahn JD, Martin RJ, Silkoff PE, Sundstrom DA, Murphy J, Szefler SJ.
Safety and application of induced sputum analysis in childhood asthma. J Allergy Clin
Immunol 2004;114(3):575-582.
53. Covar RA, Spahn JD, Murphy JR, Szefler SJ. Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med
2004;170(3):234-241.
54. Crimi N, Li Gotti F, Mangano G, Paolino G, Mastruzzo C, Vancheri C, Lisitano N,
Polosa R. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms. Ann Ital Med Int
2004;19(2):98-108.
55. Dahl R, Creemers JP, Van Noord J, Sips A, Della Cioppa G, Thomson M, Andriano
K, Kottakis J, Fashola T. Comparable efficacy and tolerability of formoterol (Foradil) administered via a novel multi-dose dry powder inhaler (Certihaler) or the Aerolizer dry powder inhaler in patients with persistent asthma. Respiration 2004;71(2):126-133.
56. Daley MF, Barrow J, Pearson K, Crane LA, Gao D, Stevenson JM, Berman S, Kempe
A. Identification and recall of children with chronic medical conditions for influenza vaccination. Pediatrics 2004;113(1 Pt 1):e26-33.
57. Danesch UC. Petasites hybridus (Butterbur root) extract in the treatment of asthma-an open trial. Altern Med Rev 2004;9(1):54-62.
58. Delvaux M, Henket M, Lau L, Kange P, Bartsch P, Djukanovic R, Louis R.
Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma. Thorax 2004;59(2):111-115.
59. Dente FL, Bacci E, Bartoli ML, Cianchetti S, Di Franco A, Giannini D, Taccola M,
Vagaggini B, Paggiaro PL. One week treatment with salmeterol does not prevent early and late asthmatic responses and sputum eosinophilia induced by allergen challenge in asthmatics. Pulm Pharmacol Ther 2004;17(3):147-153.
60. Djukanovic R, Wilson SJ, Kraft M, Jarjour NN, Steel M, Chung KF, Bao W, Fowler-
Taylor A, Matthews J, Busse WW, Holgate ST, Fahy JV. Effects of treatment with antiimmunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am
J Respir Crit Care Med 2004;170(6):583-593.
61. Dolan CM, Fraher KE, Bleecker ER, Borish L, Chipps B, Hayden ML, Weiss S,
Zheng B, Johnson C, Wenzel S. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma
Immunol 2004;92(1):32-39.
62. Dombrowski MP, Schatz M, Wise R, Thom EA, Landon M, Mabie W, Newman RB,
McNellis D, Hauth JC, Lindheimer M, Caritis SN, Leveno KJ, Meis P, Miodovnik M,
Wapner RJ, Varner MW, O'Sullivan MJ, Conway DL. Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy.
Am J Obstet Gynecol 2004;190(3):737-744.
63. Dubois EF, Derks MG, Schweitzer DH, Zwinderman AH, Dekhuijzen PN, van Boxtel
CJ. Pharmacokinetic/pharmacodynamic modelling of effects of dexamethasone and prednisolone in combination with endogenous cortisol on lymphocyte counts and systemic markers of bone turn over and inflammation in healthy and asthmatic men. Eur
J Clin Pharmacol 2004;60(5):315-328.

64. Epstein GN, Halper JP, Barrett EA, Birdsall C, McGee M, Baron KP, Lowenstein S.
A pilot study of mind-body changes in adults with asthma who practice mental imagery.
Altern Ther Health Med 2004;10(4):66-71.
65. Everden P, Campbell M, Harnden C, McGoldrick H, Bodalia B, Manion V, Reynia S.
Eformoterol Turbohaler compared with salmeterol by dry powder inhaler in asthmatic children not controlled on inhaled corticosteroids. Pediatr Allergy Immunol
2004;15(1):40-47.
66. Fardon TC, Lee DK, Haggart K, McFarlane LC, Lipworth BJ. Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate. Am J
Respir Crit Care Med 2004;170(9):960-966.
67. Fisher EB, Strunk RC, Sussman LK, Sykes RK, Walker MS. Community organization to reduce the need for acute care for asthma among African American children in low-income neighborhoods: the Neighborhood Asthma Coalition. Pediatrics
2004;114(1):116-123.
68. FitzGerald JM, Becker A, Sears MR, Mink S, Chung K, Lee J. Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax
2004;59(7):550-556.
69. Gabrijelcic J, Casas A, Rabinovich RA, Roca J, Barbera JA, Chung KF, Rodriguez-
Roisin R. Formoterol protects against platelet-activating factor-induced effects in asthma.
Eur Respir J 2004;23(1):71-75.
70. Gagro A, Aberle N, Rabatic S, Ajduk J, Jelacic J, Dekaris D. Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children.
Clin Exp Allergy 2004;34(6):939-944.
71. Gilliland FD, Li YF, Saxon A, Diaz-Sanchez D. Effect of glutathione-S-transferase
M1 and P1 genotypes on xenobiotic enhancement of allergic responses: randomised, placebo-controlled crossover study. Lancet 2004;363(9403):119-125.
72. Giner J, Torrejon M, Ramos A, Casan P, Granel C, Plaza V, Belda J, Sanchis J.
[Patient preference in the choice of dry powder inhalers]. Arch Bronconeumol
2004;40(3):106-109.
73. Girard F, Chaboillez S, Cartier A, Cote J, Hargreave FE, Labrecque M, Malo JL,
Tarlo SM, Lemiere C. An effective strategy for diagnosing occupational asthma: use of induced sputum. Am J Respir Crit Care Med 2004;170(8):845-850.
74. Godfrey S, Uwyyed K, Springer C, Avital A. Is clinical wheezing reliable as the endpoint for bronchial challenges in preschool children? Pediatr Pulmonol
2004;37(3):193-200.
75. Gohlke H, Illig T, Bahnweg M, Klopp N, Andre E, Altmuller J, Herbon N, Werner
M, Knapp M, Pescollderungg L, Boner A, Malerba G, Pignatti PF, Wjst M. Association of the interleukin-1 receptor antagonist gene with asthma. Am J Respir Crit Care Med
2004;169(11):1217-1223.
76. Griese M, Ramakers J, Krasselt A, Starosta V, Van Koningsbruggen S, Fischer R,
Ratjen F, Mullinger B, Huber RM, Maier K, Rietschel E, Scheuch G. Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. Am J
Respir Crit Care Med 2004;169(7):822-828.
77. Griffiths C, Foster G, Barnes N, Eldridge S, Tate H, Begum S, Wiggins M, Dawson
C, Livingstone AE, Chambers M, Coats T, Harris R, Feder GS. Specialist nurse intervention to reduce unscheduled asthma care in a deprived multiethnic area: the east

London randomised controlled trial for high risk asthma (ELECTRA). Bmj
2004;328(7432):144.
78. Griffiths AL, Sim D, Strauss B, Rodda C, Armstrong D, Freezer N. Effect of highdose fluticasone propionate on bone density and metabolism in children with asthma.
Pediatr Pulmonol 2004;37(2):116-121.
79. Guilbert TW, Morgan WJ, Krawiec M, Lemanske RF, Jr., Sorkness C, Szefler SJ,
Larsen G, Spahn JD, Zeiger RS, Heldt G, Strunk RC, Bacharier LB, Bloomberg GR,
Chinchilli VM, Boehmer SJ, Mauger EA, Mauger DT, Taussig LM, Martinez FD. The
Prevention of Early Asthma in Kids study: design, rationale and methods for the
Childhood Asthma Research and Education network. Control Clin Trials 2004;25(3):286-
310.
80. Halterman JS, Szilagyi PG, Yoos HL, Conn KM, Kaczorowski JM, Holzhauer RJ,
Lauver SC, Neely TL, Callahan PM, McConnochie KM. Benefits of a school-based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Arch Pediatr Adolesc Med 2004;158(5):460-467.
81. Hampel FC, Jr., Sugar M, Parasuraman B, Uryniak T, Liljas B. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) improves health-related quality of life in adults previously receiving inhaled corticosteroids. Adv Ther 2004;21(1):27-38.
82. Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, Wise R, Atmar RL.
Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol 2004;113(4):717-724.
83. Haque MR, Hossain MM, Kundu SC, Kabir S, Alam S, Chowdhury WA, Faruque
GM. A study of functional endoscopic sinus surgery technique. Mymensingh Med J
2004;13(1):39-42.
84. Harrison TW, Oborne J, Newton S, Tattersfield AE. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet
2004;363(9405):271-275.
85. Hayden JT, Smith N, Woolf DA, Barry PW, O'Callaghan C. A randomised crossover trial of facemask efficacy. Arch Dis Child 2004;89(1):72-73.
86. Heitmann BL, Anhoj J, Bisgaard AM, Ward L, Bisgaard H. Changes in body water distribution during treatment with inhaled steroid in pre-school children. Ann Hum Biol
2004;31(3):333-341.
87. Helenius I, Lumme A, Ounap J, Obase Y, Rytila P, Sarna S, Alaranta A, Remes V,
Haahtela T. No effect of montelukast on asthma-like symptoms in elite ice hockey players. Allergy 2004;59(1):39-44.
88. Hendeles L, Beaty R, Ahrens R, Stevens G, Harman EM. Response to inhaled albuterol during nocturnal asthma. J Allergy Clin Immunol 2004;113(6):1058-1062.
89. Holgate ST, Chuchalin AG, Hebert J, Lotvall J, Persson GB, Chung KF, Bousquet J,
Kerstjens HA, Fox H, Thirlwell J, Cioppa GD. Efficacy and safety of a recombinant antiimmunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy
2004;34(4):632-638.
90. Homer SD. Effect of education on school-age children's and parents' asthma management. J Spec Pediatr Nurs 2004;9(3):95-102.
91. Homs-Corbera A, Fiz JA, Morera J, Jane R. Time-frequency detection and analysis of wheezes during forced exhalation. IEEE Trans Biomed Eng 2004;51(1):182-186.

92. Horak F, Jr., Matthews S, Ihorst G, Arshad SH, Frischer T, Kuehr J, Schwieger A,
Forster J. Effect of mite-impermeable mattress encasings and an educational package on the development of allergies in a multinational randomized, controlled birth-cohort study
-- 24 months results of the Study of Prevention of Allergy in Children in Europe. Clin
Exp Allergy 2004;34(8):1220-1225.
93. Horiguchi T, Kondo R, Miyazaki J, Torigoe H, Tachikawa S. [Clinical evaluation of tulobuterol patch in patients with mild or moderate persistent bronchial asthma-effects of long-term treatment on airway inflammation and hypersensitivity]. Nihon Kokyuki
Gakkai Zasshi 2004;42(2):132-137.
94. Horiguchi T, Kondo R, Miyazaki J, Fukumokto K, Torigoe H. Clinical evaluation of a transdermal therapeutic system of the beta2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma. Arzneimittelforschung 2004;54(5):280-285.
95. Humbert M, Beasley R, Ayres J, Slavin R, Hebert J, Bousquet J, Beeh KM, Ramos S,
Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K. Benefits of omalizumab as addon therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy
2005;60(3):309-316.
96. Hung CH, Lee MY, Tsai YG, Cheng SN, Yang KD. Hyposensitization therapy reduced exhaled nitric oxide in asthmatic children with corticosteroid dependency. Acta
Paediatr Taiwan 2004;45(2):89-93.
97. Hunt LW, Frigas E, Butterfield JH, Kita H, Blomgren J, Dunnette SL, Offord KP,
Gleich GJ. Treatment of asthma with nebulized lidocaine: a randomized, placebocontrolled study. J Allergy Clin Immunol 2004;113(5):853-859.
98. Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM, Edelman JM.
Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study. Ann Allergy Asthma Immunol
2004;92(6):641-648.
99. Ind PW, Haughney J, Price D, Rosen JP, Kennelly J. Adjustable and fixed dosing with budesonide/ formoterol via a single inhaler in asthma patients: the ASSURE study.
Respir Med 2004;98(5):464-475.
100. Iqbal S, Ritson S, Prince I, Denyer J, Everard ML. Drug delivery and adherence in young children. Pediatr Pulmonol 2004;37(4):311-317.
101. Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, Deykin A,
Fagan JK, Fahy JV, Fish J, Kraft M, Kunselman SJ, Lazarus SC, Lemanske RF, Jr.,
Liggett SB, Martin RJ, Mitra N, Peters SP, Silverman E, Sorkness CA, Szefler SJ,
Wechsler ME, Weiss ST, Drazen JM. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet
2004;364(9444):1505-1512.
102. Jackson CM, Lee DK, Lipworth BJ. The effects of butterbur on the histamine and allergen cutaneous response. Ann Allergy Asthma Immunol 2004;92(2):250-254.
103. Jackson AC, Murphy MM, Rassulo J, Celli BR, Ingram RH, Jr. Deep breath reversal and exponential return of methacholine-induced obstruction in asthmatic and nonasthmatic subjects. J Appl Physiol 2004;96(1):137-142.
104. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. Bmj 2004;328(7437):434.

105. Jessop DC, Rutter DR, Sharma D, Albery IP. Emotion and adherence to treatment in people with asthma: an application of the emotional stroop paradigm. Br J Psychol
2004;95(Pt 2):127-147.
106. Jones CA, Morphew T, Clement LT, Kimia T, Dyer M, Li M, Hanley-Lopez J. A school-based case identification process for identifying inner city children with asthma: the Breathmobile program. Chest 2004;125(3):924-934.
107. Jonsson B, Berggren F, Svensson K, O'Byrne PM. An economic evaluation of combination treatment with budesonide and formoterol in patients with mild-to-moderate persistent asthma. Respir Med 2004;98(11):1146-1154.
108. Joos GF, Vincken W, Louis R, Schelfhout VJ, Wang JH, Shaw MJ, Cioppa GD,
Pauwels RA. Dual tachykinin NK1/NK2 antagonist DNK333 inhibits neurokinin Ainduced bronchoconstriction in asthma patients. Eur Respir J 2004;23(1):76-81.
109. Kaae R, Agertoft L, Pedersen S, Nordvall SL, Pedroletti C, Bengtsson T, Johannes-
Hellberg I, Rosenborg J. Cumulative high doses of inhaled formoterol have less systemic effects in asthmatic children 6-11 years-old than cumulative high doses of inhaled terbutaline. Br J Clin Pharmacol 2004;58(4):411-418.
110. Kamps AW, Roorda RJ, Kimpen JL, Overgoor-van de Groes AW, van Helsdingen-
Peek LC, Brand PL. Impact of nurse-led outpatient management of children with asthma on healthcare resource utilisation and costs. Eur Respir J 2004;23(2):304-309.
111. Kanazawa H, Hirata K, Yoshikawa J. Increased responses to inhaled oxitropium bromide in asthmatic patients with active hepatitis C virus infection. Chest
2004;125(4):1368-1371.
112. Kanazawa H, Yoshikawa J. Accelerated decline in lung function and impaired reversibility with salbutamol in asthmatic patients with chronic hepatitis C virus infection: a 6-year follow-up study. Am J Med 2004;116(11):749-752.
113. Kanazawa H, Yoshikawa T, Hirata K, Yoshikawa J. Effects of pranlukast administration on vascular endothelial growth factor levels in asthmatic patients. Chest
2004;125(5):1700-1705.
114. Kannisto S, Laatikainen A, Taivainen A, Savolainen K, Tukiainen H, Voutilainen R.
Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients. Eur J Endocrinol
2004;150(5):687-690.
115. Karaman O, Sunneli L, Uzuner N, Islekel H, Turgut CS, Kose S, Tezcan D, Coker
C, Erbayraktar Z. Evaluation of montelukast in 8 to 14 year old children with mild persistent asthma and compared with inhaled corticosteroids. Allergol Immunopathol
(Madr) 2004;32(1):21-27.
116. Kemp JP, Osur S, Shrewsbury SB, Herje NE, Duke SP, Harding SM, Faulkner K,
Crim CC. Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial. Mayo Clin Proc
2004;79(4):458-466.
117. Kimata H. Effect of viewing a humorous vs. nonhumorous film on bronchial responsiveness in patients with bronchial asthma. Physiol Behav 2004;81(4):681-684.
118. Kostadima E, Tsiodras S, Alexopoulos EI, Kaditis AG, Mavrou I, Georgatou N,
Papamichalopoulos A. Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma. Eur Respir J 2004;23(5):714-717.

119. Koulouris NG, Latsi P, Stavrou E, Chroneou A, Gaga M, Jordanoglou J.
Unevenness of ventilation assessed by the expired CO(2) gas volume versus V(T) curve in asthmatic patients. Respir Physiol Neurobiol 2004;140(3):293-300.
120. Kraft WK, Steiger B, Beussink D, Quiring JN, Fitzgerald N, Greenberg HE,
Waldman SA. The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers. J Clin Pharmacol 2004;44(1):67-72.
121. Kukreja S, Sanjay S, Ghosh G, Aggarwal KK, Moharana A. Montelukast - evaluation in 6 to 14 years old children with persistent asthma - pediatric montelukast study group. Indian J Pediatr 2004;71(9):811-815.
122. Kumar SS, Shanmugasundaram KR. Amrita Bindu--an antioxidant inducer therapy in asthma children. J Ethnopharmacol 2004;90(1):105-114.
123. Kwon HL, Belanger K, Bracken MB. Effect of pregnancy and stage of pregnancy on asthma severity: a systematic review. Am J Obstet Gynecol 2004;190(5):1201-1210.
124. Lahn M, Bijur P, Gallagher EJ. Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest 2004;126(2):362-368.
125. Laurant MG, Hermens RP, Braspenning JC, Sibbald B, Grol RP. Impact of nurse practitioners on workload of general practitioners: randomised controlled trial. Bmj
2004;328(7445):927.
126. Lebras-Isabet MN, Beydon N, Chevreul K, Marchand V, Corniou O, Koussou M,
D'Acremont G, Bourrillon A. [Outcome evaluation of education in asthmatic children: the Robert-Debre hospital's experience]. Arch Pediatr 2004;11(10):1185-1190.
127. Lee DK, Jackson CM, Haggart K, Lipworth BJ. Repeated dosing effects of mediator antagonists in inhaled corticosteroid-treated atopic asthmatic patients. Chest
2004;125(4):1372-1377.
128. Lee DK, Bates CE, Lipworth BJ. Acute systemic effects of inhaled salbutamol in asthmatic subjects expressing common homozygous beta2-adrenoceptor haplotypes at positions 16 and 27. Br J Clin Pharmacol 2004;57(1):100-104.
129. Lee DK, Bates CE, Currie GP, Cowan LM, McFarlane LC, Lipworth BJ. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function. Ann Allergy Asthma Immunol
2004;93(3):253-258.
130. Lee DK, Jackson CM, Bates CE, Lipworth BJ. Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol. Thorax 2004;59(8):662-667.
131. Lee DK, Haggart K, Robb FM, Lipworth BJ. Butterbur, a herbal remedy, confers complementary anti-inflammatory activity in asthmatic patients receiving inhaled corticosteroids. Clin Exp Allergy 2004;34(1):110-114.
132. Lee DK, Gray RD, Wilson AM, Robb FM, Soutar PC, Lipworth BJ. Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma. Br J Clin Pharmacol 2004;58(1):34-39.
133. Lee DK, Haggart K, Currie GP, Bates CE, Lipworth BJ. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma. Br J Clin Pharmacol 2004;58(1):26-33.

134. Lee DK, Haggart K, Robb FM, Lipworth BJ. Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma. Eur Respir J
2004;24(2):226-230.
135. Lee SL, Wong W, Lau YL. Increasing prevalence of allergic rhinitis but not asthma among children in Hong Kong from 1995 to 2001 (Phase 3 International Study of Asthma and Allergies in Childhood). Pediatr Allergy Immunol 2004;15(1):72-78.
136. Lehrer PM, Vaschillo E, Vaschillo B, Lu SE, Scardella A, Siddique M, Habib RH.
Biofeedback treatment for asthma. Chest 2004;126(2):352-361.
137. Li YL, Luo F, Zhang JY, Liu C. [Clinical study on effect of acupoint sticking of chuanfuling in dog-days in preventing and treating children asthma in remission stage].
Zhongguo Zhong Xi Yi Jie He Za Zhi 2004;24(7):601-604.
138. Lin YZ, Huang FY. Comparison of breath-actuated and conventional constant-flow jet nebulizers in treating acute asthmatic children. Acta Paediatr Taiwan 2004;45(2):73-
76.
139. Liu LL, Gallaher MM, Davis RL, Rutter CM, Lewis TC, Marcuse EK. Use of a respiratory clinical score among different providers. Pediatr Pulmonol 2004;37(3):243-
248.
140. Lonnkvist K, Anderson M, Hedlin G, Svartengren M. Exhaled NO and eosinophil markers in blood, nasal lavage and sputum in children with asthma after withdrawal of budesonide. Pediatr Allergy Immunol 2004;15(4):351-358.
141. Lonnkvist K, Anderson M, Hedlin G, Svartengren M. Exhaled NO and eosinophil markers in blood, nasal lavage and sputum in children with asthma after withdrawal of budesonide. Pediatr Allergy Immunol 2004;15(4):351-358.
142. Lozano P, Finkelstein JA, Carey VJ, Wagner EH, Inui TS, Fuhlbrigge AL, Soumerai
SB, Sullivan SD, Weiss ST, Weiss KB. A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II Study. Arch Pediatr
Adolesc Med 2004;158(9):875-883.
143. Luijk B, Kempsford RD, Wright AM, Zanen P, Lammers JW. Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction. Eur
Respir J 2004;23(4):559-564.
144. Maestrelli P, Zanolla L, Pozzan M, Fabbri LM. Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite. J Allergy Clin Immunol 2004;113(4):643-649.
145. Mahajan P, Haritos D, Rosenberg N, Thomas R. Comparison of nebulized magnesium sulfate plus albuterol to nebulized albuterol plus saline in children with acute exacerbations of mild to moderate asthma. J Emerg Med 2004;27(1):21-25.
146. Martinez-Moragon E, Plaza V, Serrano J, Picado C, Galdiz JB, Lopez-Vina A,
Sanchis J. Near-fatal asthma related to menstruation. J Allergy Clin Immunol
2004;113(2):242-244.
147. Masoli M, Weatherall M, Holt S, Beasley R. Systematic review of the dose-response relation of inhaled fluticasone propionate. Arch Dis Child 2004;89(10):902-907.
148. Massie J, Efron D, Cerritelli B, South M, Powell C, Haby MM, Gilbert E, Vidmar S,
Carlin J, Robertson CF. Implementation of evidence based guidelines for paediatric asthma management in a teaching hospital. Arch Dis Child 2004;89(7):660-664.

149. Mastalerz L, Setkowicz M, Sanak M, Szczeklik A. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol
2004;113(4):771-775.
150. Matsumoto K, Narita S, Rerecich T, Snider DP, O'Byrne PM. Different profile of interleukin-10 production in circulating T cells from atopic asthmatics compared with healthy subjects. Can Respir J 2004;11(1):33-38.
151. McCarney RW, Lasserson TJ, Linde K, Brinkhaus B. An overview of two Cochrane systematic reviews of complementary treatments for chronic asthma: acupuncture and homeopathy. Respir Med 2004;98(8):687-696.
152. Mendes ES, Campos MA, Hurtado A, Wanner A. Effect of montelukast and fluticasone propionate on airway mucosal blood flow in asthma. Am J Respir Crit Care
Med 2004;169(10):1131-1134.
153. Merkus PJ, van Pelt W, van Houwelingen JC, van Essen-Zandvliet LE, Duiverman
EJ, Kerrebijn KF, Quanjer PH. Inhaled corticosteroids and growth of airway function in asthmatic children. Eur Respir J 2004;23(6):861-868.
154. Migoya E, Kearns GL, Hartford A, Zhao J, van Adelsberg J, Tozzi CA, Knorr B,
Deutsch P. Pharmacokinetics of montelukast in asthmatic patients 6 to 24 months old. J
Clin Pharmacol 2004;44(5):487-494.
155. Milanese M, Peroni D, Costella S, Aralla R, Loiacono A, Barp C, Boner A,
Brusasco V. Improved bronchodilator effect of deep inhalation after allergen avoidance in asthmatic children. J Allergy Clin Immunol 2004;114(3):505-511.
156. Milani GK, Rosario Filho NA, Riedi CA, Figueiredo BC. [Nebulized budesonide to treat acute asthma in children]. J Pediatr (Rio J) 2004;80(2):106-112.
157. Minai BA, Martin JE, Cohn RC. Results of a physician and respiratory therapist collaborative effort to improve long-term metered-dose inhaler technique in a pediatric asthma clinic. Respir Care 2004;49(6):600-605.
158. Morgan WJ, Crain EF, Gruchalla RS, O'Connor GT, Kattan M, Evans R, 3rd, Stout
J, Malindzak G, Smartt E, Plaut M, Walter M, Vaughn B, Mitchell H. Results of a homebased environmental intervention among urban children with asthma. N Engl J Med
2004;351(11):1068-1080.
159. Morris CR, Poljakovic M, Lavrisha L, Machado L, Kuypers FA, Morris SM, Jr.
Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J
Respir Crit Care Med 2004;170(2):148-153.
160. Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer
A, Dorinsky P. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists. Ann Allergy Asthma Immunol 2004;93(4):351-359.
161. Nave R, Bethke TD, van Marle SP, Zech K. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects. Clin Pharmacokinet
2004;43(7):479-486.
162. Niimi A, Matsumoto H, Amitani R, Nakano Y, Sakai H, Takemura M, Ueda T, Chin
K, Itoh H, Ingenito EP, Mishima M. Effect of short-term treatment with inhaled corticosteroid on airway wall thickening in asthma. Am J Med 2004;116(11):725-731.
163. Niimi A, Nguyen LT, Usmani O, Mann B, Chung KF. Reduced pH and chloride levels in exhaled breath condensate of patients with chronic cough. Thorax
2004;59(7):608-612.

164. Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De Marco E, Burastero SE,
Calori G, Benetti L, Bonazza P, Puccinelli P, Parmiani S, Bernardini R, Vierucci A.
Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004;114(4):851-857.
165. O'Sullivan S, Cormican L, Burke CM, Poulter LW. Fluticasone induces T cell apoptosis in the bronchial wall of mild to moderate asthmatics. Thorax 2004;59(8):657-
661.
166. Oba Y, Salzman GA. Cost-effectiveness analysis of omalizumab in adults and adolescents with moderate-to-severe allergic asthma. J Allergy Clin Immunol
2004;114(2):265-269.
167. Otulana B, Okikawa J, Linn L, Morishige R, Thipphawong J. Safety and pharmacokinetics of inhaled morphine delivered using the AERx system in patients with moderate-to-severe asthma. Int J Clin Pharmacol Ther 2004;42(8):456-462.
168. Overbeek SE, O'Sullivan S, Leman K, Mulder PG, Hoogsteden HC, Prins JB. Effect of montelukast compared with inhaled fluticasone on airway inflammation. Clin Exp
Allergy 2004;34(9):1388-1394.
169. Parameswaran K, Watson R, Gauvreau GM, Sehmi R, O'Byrne PM. The effect of pranlukast on allergen-induced bone marrow eosinophilopoiesis in subjects with asthma.
Am J Respir Crit Care Med 2004;169(8):915-920.
170. Parameswaran K, Liang H, Fanat A, Watson R, Snider DP, O'Byrne PM. Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma. J Allergy Clin Immunol 2004;114(1):73-79.
171. Patel PH, Welsh C, Foggs MB. Improved asthma outcomes using a coordinated care approach in a large medical group. Dis Manag 2004;7(2):102-111.
172. Pearlman DS, Peden D, Condemi JJ, Weinstein S, White M, Baitinger L, Scott C,
Ho SY, House K, Dorinsky P. Efficacy and safety of fluticasone propionate/salmeterol
HFA 134A MDI in patients with mild-to-moderate persistent asthma. J Asthma
2004;41(8):797-806.
173. Pearson PJ, Lewis SA, Britton J, Fogarty A. Vitamin E supplements in asthma: a parallel group randomised placebo controlled trial. Thorax 2004;59(8):652-656.
174. Peat JK, Mihrshahi S, Kemp AS, Marks GB, Tovey ER, Webb K, Mellis CM,
Leeder SR. Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study. J Allergy Clin Immunol
2004;114(4):807-813.
175. Perng DW, Huang HY, Lee YC, Perng RP. Leukotriene modifier vs inhaled corticosteroid in mild-to-moderate asthma: clinical and anti-inflammatory effects. Chest
2004;125(5):1693-1699.
176. Perry TT, Corren J, Philip G, Kim EH, Conover-Walker MK, Malice MP, Massaad
R, Dass SB, Reiss TF, Wood RA. Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure. Ann Allergy Asthma
Immunol 2004;93(5):431-438.
177. Philip G, Nayak AS, Berger WE, Leynadier F, Vrijens F, Dass SB, Reiss TF. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004;20(10):1549-1558.

178. Phillips K, Oborne J, Lewis S, Harrison TW, Tattersfield AE. Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide. Thorax
2004;59(1):26-30.
179. Phillips K, Oborne J, Harrison TW, Tattersfield AE. Use of sequential quadrupling dose regimens to study efficacy of inhaled corticosteroids in asthma. Thorax
2004;59(1):21-25.
180. Phipatanakul W, Cronin B, Wood RA, Eggleston PA, Shih MC, Song L, Tachdjian
R, Oettgen HC. Effect of environmental intervention on mouse allergen levels in homes of inner-city Boston children with asthma. Ann Allergy Asthma Immunol
2004;92(4):420-425.
181. Phipps S, Flood-Page P, Menzies-Gow A, Ong YE, Kay AB. Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin. J Invest Dermatol 2004;122(6):1406-1412.
182. Pietropaoli AP, Frampton MW, Hyde RW, Morrow PE, Oberdorster G, Cox C,
Speers DM, Frasier LM, Chalupa DC, Huang LS, Utell MJ. Pulmonary function, diffusing capacity, and inflammation in healthy and asthmatic subjects exposed to ultrafine particles. Inhal Toxicol 2004;16 Suppl 1:59-72.
183. Pilotto LS, Nitschke M, Smith BJ, Pisaniello D, Ruffin RE, McElroy HJ, Martin J,
Hiller JE. Randomized controlled trial of unflued gas heater replacement on respiratory health of asthmatic schoolchildren. Int J Epidemiol 2004;33(1):208-214.
184. Pinto JM, Assanasen P, Baroody FM, Naureckas E, Solway J, Naclerio RM.
Treatment of nasal inflammation decreases the ability of subjects with asthma to condition inspired air. Am J Respir Crit Care Med 2004;170(8):863-869.
185. Pohunek P, Matulka M, Rybnicek O, Kopriva F, Honomichlova H, Svobodova T.
Dose-related efficacy and safety of formoterol (Oxis) Turbuhaler compared with salmeterol Diskhaler in children with asthma. Pediatr Allergy Immunol 2004;15(1):32-
39.
186. Powell H, Gibson PG. Initial starting dose of inhaled corticosteroids in adults with asthma: a systematic review. Thorax 2004;59(12):1041-1045.
187. Raby BA, Silverman EK, Kwiatkowski DJ, Lange C, Lazarus R, Weiss ST.
ADAM33 polymorphisms and phenotype associations in childhood asthma. J Allergy
Clin Immunol 2004;113(6):1071-1078.
188. Rathkopf MM, Quinn JM, Proffer DL, Napoli DC. Patient knowledge of immunotherapy before and after an educational intervention: a comparison of 2 methods.
Ann Allergy Asthma Immunol 2004;93(2):147-153.
189. Reynolds NA, Scott LJ. Ciclesonide. Drugs 2004;64(5):511-519; discussion 520-
511.
190. Rohatagi S, Shah B, Zhang J, Zeng Z, Kirkesseli S, Jensen BK. Estimating mass balance for inhaled drugs in humans: an example with a VLA-4 antagonist, IVL745. J
Clin Pharmacol 2004;44(4):348-358.
191. Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, Moreno-Macias H, Reyes-Ruiz NI,
Estela del Rio-Navarro B, Hernandez-Avila M, London SJ. Genetic polymorphism of
GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City. Thorax 2004;59(1):8-10.

192. Salpeter SR, Ormiston TM, Salpeter EE. Meta-analysis: respiratory tolerance to regular beta2-agonist use in patients with asthma. Ann Intern Med 2004;140(10):802-
813.
193. Salpeter SR. Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review. Drugs Aging 2004;21(6):405-414.
194. Schaffer SD, Tian L. Promoting adherence: effects of theory-based asthma education. Clin Nurs Res 2004;13(1):69-89.
195. Schei MA, Hessen JO, Smith KR, Bruce N, McCracken J, Lopez V. Childhood asthma and indoor woodsmoke from cooking in Guatemala. J Expo Anal Environ
Epidemiol 2004;14 Suppl 1:S110-117.
196. Schermer TR, Hoff WJ, Greefhorst AP, Creemers JP, Sips AP, Westbroek J, van
Herwaarden CL. Profiles of measured and perceived bronchodilation. A placebocontrolled cross-over trial comparing formoterol and salmeterol in moderate persistent asthma. Pulm Pharmacol Ther 2004;17(4):205-212.
197. Schonberger HJ, Maas T, Dompeling E, Knottnerus JA, van Weel C, van Schayck
CP. Compliance of asthmatic families with a primary prevention programme of asthma and effectiveness of measures to reduce inhalant allergens--a randomized trial. Clin Exp
Allergy 2004;34(7):1024-1031.
198. Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP,
Naya IP, Hultquist C. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin
2004;20(9):1403-1418.
199. Senna G, Bilo MB, Antonicelli L, Schiappoli M, Crivellaro MA, Bonadonna P,
Dama AR. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients. Allerg Immunol (Paris)
2004;36(6):215-218.
200. Sharma A, Madaan A. Nebulized salbutamol vs salbutamol and ipratropium combination in asthma. Indian J Pediatr 2004;71(2):121-124.
201. Sheth KK, Cook CK, Philpot EE, Prillaman BA, Witham LA, Faris MA, Klein KC,
Rickard KA. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function. Allergy Asthma Proc
2004;25(2):115-120.
202. Shirtcliffe PM, Easthope SE, Weatherall M, Beasley R. Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guerin in adult asthma. Clin Exp Allergy 2004;34(2):207-212.
203. Silkoff PE, Romero FA, Gupta N, Townley RG, Milgrom H. Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin
E antibody. Pediatrics 2004;113(4):e308-312.
204. Silkoff PE, Bates CA, Meiser JB, Bratton DL. Single-breath exhaled nitric oxide in preschool children facilitated by a servo-controlled device maintaining constant flow.
Pediatr Pulmonol 2004;37(6):554-558.
205. Silverman RA, Nowak RM, Korenblat PE, Skobeloff E, Chen Y, Bonuccelli CM,
Miller CJ, Simonson SG. Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial. Chest 2004;126(5):1480-1489.

206. Sin DD, Bell NR, Man SF. Effects of increased primary care access on process of care and health outcomes among patients with asthma who frequent emergency departments. Am J Med 2004;117(7):479-483.
207. Sin DD, Man J, Sharpe H, Gan WQ, Man SF. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis.
JAMA 2004;292(3):367-376.
208. Sjosward KN, Hmani M, Davidsson A, Soderkvist P, Schmekel B. Single-isomer Rsalbutamol is not superior to racemate regarding protection for bronchial hyperresponsiveness. Respir Med 2004;98(10):990-999.
209. Smith AD, Cowan JO, Filsell S, McLachlan C, Monti-Sheehan G, Jackson P, Taylor
DR. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 2004;169(4):473-478.
210. Sopo SM, Macchiaiolo M, Zorzi G, Tripodi S. Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature. Arch Dis Child
2004;89(7):620-624.
211. Spector SL, Tan RA. Effectiveness of montelukast in the treatment of cough variant asthma. Ann Allergy Asthma Immunol 2004;93(3):232-236.
212. Stelmach I, Majak P, Jerzynska J, Stelmach W, Kuna P. Comparative effect of triamcinolone, nedocromil and montelukast on asthma control in children: A randomized pragmatic study. Pediatr Allergy Immunol 2004;15(4):359-364.
213. Stenfors N, Nordenhall C, Salvi SS, Mudway I, Soderberg M, Blomberg A,
Helleday R, Levin JO, Holgate ST, Kelly FJ, Frew AJ, Sandstrom T. Different airway inflammatory responses in asthmatic and healthy humans exposed to diesel. Eur Respir J
2004;23(1):82-86.
214. Storms W, Chervinsky P, Ghannam AF, Bird S, Hustad CM, Edelman JM. A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge. Respir Med 2004;98(11):1051-1062.
215. Strand AM, Luckow A. Initiation of maintenance treatment of persistent asthma: salmeterol/fluticasone propionate combination treatment is more effective than inhaled steroid alone. Respir Med 2004;98(10):1008-1015.
216. Szefler SJ, Lyzell E, Fitzpatrick S, Cruz-Rivera M. Safety profile of budesonide inhalation suspension in the pediatric population: worldwide experience. Ann Allergy
Asthma Immunol 2004;93(1):83-90.
217. Taylor ES, Smith AD, Cowan JO, Herbison GP, Taylor DR. Effect of caffeine ingestion on exhaled nitric oxide measurements in patients with asthma. Am J Respir Crit
Care Med 2004;169(9):1019-1021.
218. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids.
Am J Respir Crit Care Med 2004;170(6):601-605.
219. TePas EC, Hoyte EG, McIntire JJ, Umetsu DT. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals. Ann Allergy
Asthma Immunol 2004;92(1):25-31.
220. Teper AM, Colom AJ, Kofman CD, Maffey AF, Vidaurreta SM, Bergada I. Effects of inhaled fluticasone propionate in children less than 2 years old with recurrent wheezing. Pediatr Pulmonol 2004;37(2):111-115.

221. Tucker KL, Olson B, Bakun P, Dallal GE, Selhub J, Rosenberg IH. Breakfast cereal fortified with folic acid, vitamin B-6, and vitamin B-12 increases vitamin concentrations and reduces homocysteine concentrations: a randomized trial. Am J Clin Nutr
2004;79(5):805-811.
222. van der Woude HJ, Boorsma M, Bergqvist PB, Winter TH, Aalbers R.
Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction. Pulm Pharmacol Ther 2004;17(2):89-95.
223. Vanto T, Hamalainen KM, Vahteristo M, Wille S, Nja F, Hyldebrandt N.
Comparison of two budesonide dry powder inhalers in the treatment of asthma in children. J Aerosol Med 2004;17(1):15-24.
224. von Berg A, Jeena PM, Soemantri PA, Vertruyen A, Schmidt P, Gerken F, Razzouk
H. Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft
Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma.
Pediatr Pulmonol 2004;37(3):264-272.
225. Ward DJ, Ayres JG. Particulate air pollution and panel studies in children: a systematic review. Occup Environ Med 2004;61(4):e13.
226. Wardlaw A, Larivee P, Eller J, Cockcroft DW, Ghaly L, Harris AG. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate. Ann Allergy Asthma
Immunol 2004;93(1):49-55.
227. Warsi A, Wang PS, LaValley MP, Avorn J, Solomon DH. Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med 2004;164(15):1641-1649.
228. Weiss KB, Liljas B, Schoenwetter W, Schatz M, Luce BR. Effectiveness of budesonide administered via dry-powder inhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler for adults with persistent asthma in managed care settings. Clin Ther 2004;26(1):102-114.
229. Wensley D, Silverman M. Peak flow monitoring for guided self-management in childhood asthma: a randomized controlled trial. Am J Respir Crit Care Med
2004;170(6):606-612.
230. Witt K, Knudsen E, Ditlevsen S, Hollnagel H. Academic detailing has no effect on prescribing of asthma medication in Danish general practice: a 3-year randomized controlled trial with 12-monthly follow-ups. Fam Pract 2004;21(3):248-253.
231. Woessner KM, Simon RA, Stevenson DD. Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol
2004;93(4):339-344.
232. Wraight JM, Smith AD, Cowan JO, Flannery EM, Herbison GP, Taylor DR.
Adverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequate. Respirology 2004;9(2):215-221.
233. Zeiger RS, Baker JW, Kaplan MS, Pearlman DS, Schatz M, Bird S, Hustad C,
Edelman J. Variability of symptoms in mild persistent asthma: baseline data from the
MIAMI study. Respir Med 2004;98(9):898-905.
234. Zhao JQ, Shao J, Zhong WW. [Clinical study on effect of chuankezhi injection in treating children with bronchial asthma]. Zhongguo Zhong Xi Yi Jie He Za Zhi
2004;24(6):511-513.

235. Zimmerman B, D'Urzo A, Berube D. Efficacy and safety of formoterol Turbuhaler when added to inhaled corticosteroid treatment in children with asthma. Pediatr Pulmonol
2004;37(2):122-127.